The median age of participants was 59 years (range, 32-72 years), 21 (72.4%) had undergone at least 1 prior PSA test for prostate cancer screening, and 14 (66.7%) of those screened had been diagnosed with prostate cancer (eTable 2 in Supplement 1). The gene discussed is KLK3; the disease is prostate carcinoma.